Wu, Yingying
Xu, Lingzi
Wu, Zhaomin
Cao, Xiaolan
Xue, Gui
Wang, Yufeng
Yang, Binrang
Funding for this research was provided by:
Sanming Project of Medicine in Shenzhen “The ADHD research group from Peking University Sixth hospital” (SZSM201612036, SZSM201612036, SZSM201612036, SZSM201612036)
Article History
Received: 17 November 2022
Accepted: 27 December 2022
First Online: 16 January 2023
Declarations
:
: This study was conducted at Shenzhen Children’s Hospital, Shenzhen, China between April 2021 and January 2022. The study was approved by the Ethics Committee of Shenzhen Children’s Hospital (Reference 2021055) following the criteria set by the Declaration of Helsinki. Written informed consent was obtained from all parents or guardians, as well as from participants themselves if they were 8 years old or older.
: X.G. is the Chief scientific advisor for Infinite Brain Technology. YY.W. and LZ.X. serve as medical advisor for Infinite Brain Technology.